Target intelligence / Profile preview

Serum amyloid A2–serum amyloid A4 readthrough (SAA2-SAA4)

Target
SAA2-SAA4
Molecular classification
Other (fusion gene read-through product)
01

Overview

The SAA2-SAA4 readthrough gene locus on chromosome 11 produces a transcript derived from the fusion of the SAA2 and SAA4 genes. This read-through transcript leads to a protein combining elements of both SAA2 and SAA4. These genes belong to the serum amyloid A (SAA) family, which encodes highly conserved apolipoproteins involved in the acute-phase inflammatory response and lipid metabolism[1][2][5]. However, the specific biological function or clinical significance of the SAA2-SAA4 fusion protein has not been established, and it is not regarded as a receptor, enzyme, or conventional therapeutic target. Instead, the locus reflects a rare instance of natural read-through transcription and is mostly categorized for genomic annotation purposes rather than functional biology[3][5].

Other names
SAA2-SAA4 proteinSAA2-SAA4 read-through transcriptSAA2-SAA4SAA2-SAA4 gene

Beyond the preview

Go deeper on Serum amyloid A2–serum amyloid A4 readthrough (SAA2-SAA4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serum amyloid A2–serum amyloid A4 readthrough (SAA2-SAA4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call